Science Explorer Back to mapMap
Discussion

VirRx (United States)

Research works
12
fractional, all time
Citations
434
35.4 per fractional work
Top-10% rate
6.8%
all institutions 10.0%
Open access
24%
world 40%
International
10%
world 18%

Not ranked overall: VirRx (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does VirRx (United States) work in?

In all years, 51% of research at VirRx (United States) is in Life Sciences, 25% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (47%), Medicine (25%), Environmental Science (11%). It does 1.9× the world's share of Life Sciences.

Life Sciences: 6 fractional works · 50.6% of its workBiochemistry, Genetics and Molecular Biology: 6 fractional works · 46.9% of its workMolecular Biology: 2 fractional works · 19.3% of its workGenetics: 2 fractional works · 18.1% of its workBiotechnology: 1 fractional works · 5.6% of its workCancer Research: 0 fractional works · 4.1% of its workImmunology and Microbiology: 0 fractional works · 2.3% of its workImmunology: 0 fractional works · 1.4% of its workVirology: 0 fractional works · 1.0% of its workAgricultural and Biological Sciences: 0 fractional works · 1.4% of its workAnimal Science and Zoology: 0 fractional works · 1.4% of its workHealth Sciences: 3 fractional works · 24.7% of its workMedicine: 3 fractional works · 24.7% of its workInfectious Diseases: 1 fractional works · 9.2% of its workOncology: 1 fractional works · 4.3% of its workBiochemistry: 0 fractional works · 4.1% of its workEpidemiology: 0 fractional works · 2.9% of its workHepatology: 0 fractional works · 2.9% of its workDermatology: 0 fractional works · 0.9% of its workEmergency Medicine: 0 fractional works · 0.2% of its workPhysical Sciences: 3 fractional works · 22.1% of its workEnvironmental Science: 1 fractional works · 11.1% of its workEcology: 1 fractional works · 8.2% of its workEnvironmental Engineering: 0 fractional works · 2.7% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemistry: 1 fractional works · 8.3% of its workSpectroscopy: 1 fractional works · 8.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEngineering: 0 fractional works · 2.7% of its workMechanical Engineering: 0 fractional works · 2.7% of its workSocial Sciences: 0 fractional works · 2.7% of its workSocial Sciences: 0 fractional works · 2.7% of its workSociology and Political Science: 0 fractional works · 2.7% of its workALL ITS WORKVirRx (UnitedStates)12fractional works, all years
Life Sciences51%Physical Sciences22%Health Sciences25%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 8 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology646.9%
    2. Immunology and Microbiology02.3%
    3. Agricultural and Biological Sciences01.4%
    1. Medicine324.7%
    1. Environmental Science111.1%
    2. Chemistry18.3%
    3. Engineering02.7%
    1. Social Sciences02.7%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

    What are the most cited papers from VirRx (United States)?

    The most cited paper from VirRx (United States) is "Overexpression of the ADP (E3-11.6K) Protein Increases Cell Lysis and Spread of Adenovirus" (Konstantin Doronin, Károly Tóth, Mohan N. Kuppuswamy et al., 2003), with 124 citations. Next come "Preparation and Titration of CsCl-Banded Adenovirus Stocks" (106) and "Opportunities for greener alternatives in chemical formulations" (102).

    Most cited papers
    #PaperReleasedCitations
    1 Overexpression of the ADP (E3-11.6K) Protein Increases Cell Lysis and Spread of Adenovirus Konstantin Doronin, Károly Tóth, Mohan N. Kuppuswamy et al. · Virology Open access 2003 124
    2 Preparation and Titration of CsCl-Banded Adenovirus Stocks Ann E. Tollefson, Mohan N. Kuppuswamy, Elena V. Shashkova et al. · Humana Press eBooks Book chapter 31 Mar 2007 106
    3 Opportunities for greener alternatives in chemical formulations Philip G. Jessop, Faraz Ahmadpour, M. A. Buczynski et al. · Green Chemistry Open access 2015 102
    4 Treatment of AIDS-Related Cutaneous Kaposi's Sarcoma With Topical Alitretinoin (9-cis-Retinoic Acid) Gel Sharon Lynn Walmsley, Donald W. Northfelt, Barbara L. Melosky et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes Nov 1999 79
    5 Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects Peter A. Anton, Ronald T. Mitsuyasu, Steven G. Deeks et al. · AIDS 2003 78
    All 27 most cited papers, with filters and sorting

    Which research topics does VirRx (United States) publish most on?

    By volume: Virus-based gene therapy research, Viral Infectious Diseases and Gene Expression in Insects, Analytical Chemistry and Chromatography and Microbial Community Ecology and Physiology.

    1. 1 Virus-based gene therapy research Genetics 2 works
    2. 2 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 2 works
    3. 3 Analytical Chemistry and Chromatography Spectroscopy 1 works
    4. 4 Microbial Community Ecology and Physiology Ecology 1 works
    5. 5 Viral gastroenteritis research and epidemiology Infectious Diseases 1 works
    6. 6 Cancer Research and Treatments Biotechnology 1 works
    7. 7 Gene expression and cancer classification Molecular Biology 0 works
    8. 8 Antioxidant Activity and Oxidative Stress Biochemistry 0 works
    9. 9 Cancer, Lipids, and Metabolism Cancer Research 0 works
    10. 10 CAR-T cell therapy research Oncology 0 works

    How open and international is its research?

    Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

    openly available24.4%not open75.6%

    World: 40% of research is openly available.

    with international co-authors10.5%domestic only89.5%

    World: 18% is written across borders.

    How has VirRx (United States)'s research output changed?

    2000200520102015
    grewheldshrank

    The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

    Its share of all research

    Growing output can still be a shrinking share: all of science grows. This is VirRx (United States) as a percentage of every work published that year, 0.0000069% in 2014.

    0.00010%0.00020%0.00030%VirRx (United States)0.00000081% in 201520002010

    Fractional works of VirRx (United States) over all fractional works that year. How the balance of science has shifted.

    Other research institutions in Chesterfield

    All research institutions in Chesterfield

    Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

    Discussion

    Ask a question or share a note about VirRx (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.